Nisa Investment Advisors’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.67M Sell
13,268
-774
-6% -$97.3K 0.01% 683
2025
Q1
$1.55M Buy
14,042
+12,767
+1,001% +$1.41M 0.01% 710
2024
Q4
$174K Sell
1,275
-70
-5% -$9.56K ﹤0.01% 1332
2024
Q3
$155K Sell
1,345
-5,662
-81% -$652K ﹤0.01% 1337
2024
Q2
$965K Sell
7,007
-208
-3% -$28.6K 0.01% 889
2024
Q1
$995K Sell
7,215
-18,389
-72% -$2.54M 0.01% 881
2023
Q4
$3.37M Buy
25,604
+4,687
+22% +$618K 0.02% 512
2023
Q3
$2.35M Sell
20,917
-3,980
-16% -$448K 0.02% 621
2023
Q2
$2.35M Sell
24,897
-246
-1% -$23.2K 0.02% 638
2023
Q1
$2.55M Buy
25,143
+6,772
+37% +$685K 0.02% 603
2022
Q4
$2.19M Buy
18,371
+17,546
+2,127% +$2.1M 0.02% 707
2022
Q3
$88K Sell
825
-77
-9% -$8.21K ﹤0.01% 1547
2022
Q2
$88K Hold
902
﹤0.01% 1545
2022
Q1
$85K Sell
902
-30,852
-97% -$2.91M ﹤0.01% 1679
2021
Q4
$2.51M Buy
31,754
+27,668
+677% +$2.19M 0.02% 585
2021
Q3
$392 Sell
4,086
-1,237
-23% -$119 ﹤0.01% 1191
2021
Q2
$518 Hold
5,323
﹤0.01% 1134
2021
Q1
$518 Sell
5,323
-1,050
-16% -$102 ﹤0.01% 1162
2020
Q4
$611K Buy
6,373
+1,830
+40% +$175K ﹤0.01% 1098
2020
Q3
$437K Sell
4,543
-3,293
-42% -$317K ﹤0.01% 1083
2020
Q2
$956K Sell
7,836
-14,860
-65% -$1.81M 0.01% 804
2020
Q1
$1.96M Buy
22,696
+2,852
+14% +$247K 0.02% 538
2019
Q4
$2.13M Buy
19,844
+13,579
+217% +$1.46M 0.02% 620
2019
Q3
$565K Buy
6,265
+135
+2% +$12.2K 0.01% 1054
2019
Q2
$518K Buy
6,130
+165
+3% +$13.9K ﹤0.01% 1065
2019
Q1
$526K Buy
5,965
+358
+6% +$31.6K 0.01% 1044
2018
Q4
$400K Sell
5,607
-13,984
-71% -$998K ﹤0.01% 1063
2018
Q3
$2.41M Buy
19,591
+19,091
+3,818% +$2.35M 0.02% 586
2018
Q2
$49K Buy
500
+100
+25% +$9.8K ﹤0.01% 1455
2018
Q1
$34K Buy
+400
New +$34K ﹤0.01% 1455
2016
Q4
Sell
-1,000
Closed -$51K 1885
2016
Q3
$51K Hold
1,000
﹤0.01% 1401
2016
Q2
$45K Hold
1,000
﹤0.01% 1407
2016
Q1
$40K Buy
+1,000
New +$40K ﹤0.01% 1422